Trial intelligence / Profile preview

Molidustat Extension Study in Dialysis Patients with Renal Anemia

NCT02064426Phase 2Completed

Sponsor
Bayer
Start
Mar 2014
Primary completion
Oct 2016
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of molidustat in anemia, sponsored by Bayer. Started Mar 2014; status: completed.

02

Drugs

molidustat
03

Conditions

anemia

Beyond the preview

Go deeper on NCT02064426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02064426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call